相关实验视频
Updated: Jul 18, 2025

07:20
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
543
肺癌恶性进展中的自和糖代谢重编程:一篇评论
Yuting Li1,2,3, Tongzuo Liu1,2,3, Xiaoqun Wang1,2
1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Technology in cancer research & treatment
|August 22, 2023
概括
自和糖代谢重编程是肺癌发展的关键. 了解这些过程为晚期肺癌提供了新的治疗策略,旨在抑制疾病进展并改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 代谢途径 代谢途径
背景情况:
- 肺癌仍然是全球癌症死亡的主要原因.
- 对于晚期肺癌,有效的治疗方法有限.
- 自和糖代谢重编程在固体瘤发育中至关重要.
研究的目的:
- 审查肺癌恶性瘤中自和糖代谢的调节.
- 为新的治疗策略提供理论基础.
- 为了利用其他固体瘤的见解来治疗肺癌.
主要方法:
- 在固体瘤中对自和糖代谢的研究的文献综述.
- 分析恶性发展中的调节机制.
- 综合发现,为肺癌治疗方法提供信息.
主要成果:
- 自和糖代谢显著影响肺癌的扩散和耐药性.
- 这些途径与肺癌细胞的入侵和转移有关.
- 这些过程的失调是恶性肺瘤的标志.
结论:
- 针对自和糖代谢,为肺癌提供了一个有前途的治疗途径.
- 需要进一步的研究来将这些发现转化为有效的临床干预措施.
- 了解这些代谢变化可以指导新型抗癌药物的开发.
更多相关视频
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Autophagy
4.3K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.3K
Delivery Pathways to the Lysosome
6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K

